Omnicell Inc. Stock
Price
Target price
€26.80
€26.80
-1.470%
-0.4
-1.470%
€40.31
05.06.25 / Frankfurt
WKN: 632313 / Symbol: OMCL / Name: Omnicell / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Omnicell Inc. Stock
A loss of -1.470% shows a downward development for Omnicell Inc..
Omnicell Inc. is currently one of the favorites of our community with 10 Buy predictions and no Sell predictions.
As a result the target price of 40 € shows a positive potential of 49.25% compared to the current price of 26.8 € for Omnicell Inc..
Pros and Cons of Omnicell Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omnicell Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omnicell Inc. | -1.470% | 1.515% | 0.752% | -2.190% | -35.577% | -73.200% | -54.576% |
| Healthequity Inc. | 3.170% | 10.795% | 23.418% | 26.623% | 7.143% | 63.866% | 87.500% |
| Bruker Corp. | 2.460% | 3.959% | -3.085% | -42.488% | -39.398% | - | - |
| Integer Hldg | - | 0.962% | 0.962% | -5.405% | -17.323% | 46.853% | 41.892% |
Comments
Omnicell, Inc. (NASDAQ: OMCL) had its "overweight" rating re-affirmed by analysts at Piper Sandler.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell, Inc. (NASDAQ: OMCL) had its price target raised by analysts at Wells Fargo & Company from $35.00 to $37.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell, Inc. (NASDAQ: OMCL) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $35.00 price target on the stock, up previously from $31.00.
Show more
Ratings data for OMCL provided by MarketBeat